Some venture capitalists interviewed by MedCity News believe that digital health's $57.2 billion haul globally last year is not a sign of a bubble and that there is yet room to grow, some hedged in answering the question, while a couple sounded the alarm. Everyone agreed on one thing though: valuations need to come down.
The supply chain needs of the pharmaceutical industry are growing increasingly complex, particularly with the growth of cell and gene therapies that require timely delivery of medication components that have to be kept at stable temperatures.
A new report,Resilience in volatility: Modernizing the supply chainfrom Microsoft highlights factors that have stressed the supply chain over the past 18 months and how companies are responding to this crisis as they lay the groundwork to minimize the impact of global events in the future.
By Michael Schroeder Thursday, January 20, 2022 9:02 PM
The new infusion brings Wheel's total funding to $216 million at a time when more companies understand the need to have an on-demand consumer/patient-facing telemedicine service that Wheel possesses but may not necessarily want to build it from the ground up.
By Frank Vinluan Thursday, January 20, 2022 7:51 PM
Eleusis is developing a formulation of the psychedelic compound psilocybin that overcomes limitations of pill versions of the drug. Depression is Eleusis's lead disease target but the biotech notes that its research has shown the potential to bring psychedelic drugs beyond psychiatry.
By Michael Schroeder Thursday, January 20, 2022 2:12 PM
The New York City-based digital medicine company has been working with the health system for several years, starting in its gastroenterology department. It's providing a unified messaging platform aimed at improving care coordination and patient engagement.
By Frank Vinluan Thursday, January 20, 2022 1:13 PM
Despite the targeted approach of some cancer treatments, tumors can find ways to escape, leading patients to relapse. ImmPACT Bio will apply its Series B financing toward the development of cell therapies designed to prevent tumor escape.
Datos Health's fully customizable remote patient monitoring solution was implemented in just days at Rochester Regional Health by leveraging the user-friendly, drag and drop Care Pathways Design Studio to build a brand new remote care workflow.
Download this insightful case study to learn more!
MedCity News 611 Broadway New York, NY 10012 United States
You received this email because you are subscribed to MedCity Daily Digest from MedCity News.
Update your email preferences to choose the types of emails you receive.
No comments